DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$13.18
0.04 (0.30%)
▲
5d:
+0.61%
30d:
+12.46%
90d:
+21.14%
HOLD
MODERATE Confidence
Analysis Updated: Jul 15, 2026 12:00 AM ET
Earnings: Aug 05, 2026
19d
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DCTH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DCTH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $13.18, which is considered extended relative to its 30-day fair value range of $11.66 to $13.18. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.8) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is in a strong uptrend. Immediate support is located at $12.46, while resistance sits at $13.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.35 (+62.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a strong uptrend. Immediate support is located at $12.46, while resistance sits at $13.74.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.35 (+62.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$11.66 -
$13.18
Company Quality Score
56/100
(HOLD)
Options IV Signal
34th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
54.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 34th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.0% below Wall St target ($21.35)
Trading Range Analysis
30-Day Trading Range
$11.66 -
$13.18
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$1.53
(11.6%)
Support & Resistance Levels
Support Level
$12.46
Resistance Level
$13.74
Current Trend
Strong Uptrend
Technical data as of
Jul 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.84
Wall Street Target
$21.35
(+62.0%)
Revenue Growth (YoY)
26.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
0.6%
PE vs Historical
-25.8 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: July 16, 2026 1:32 AM ET
Data refreshes hourly during market hours. Next update: 2:32 AM
Data refreshes hourly during market hours. Next update: 2:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 53 HOLD |
